Chemotherapy: some potential risks under antineoplastic drugs handling

par L. G. Solenova, M. G. Yakubovskaya
Publié 2017-10-01

Mechanisms of carcinogenesis prevention by flavonoids

par G. A. Belitsky, K. I. Kirsanov, E. A. Lesovaya, M. G. Yakubovskaya
Publié 2015-06-01

Second primary malignancies of cancer patients: treatment-related carcinogenesis

par G. A. Belitskiy, E. A. Lesovaya, K. I. Kirsanov, M. G. Yakubovskaya
Publié 2016-09-01

Trabectedin – the DNA minor groove binder

par G. A. Belitsky, K. I. Kirsanov, E. A. Lesovaya, M. G. Yakubovskaya
Publié 2015-06-01

METHODOLOGICAL APPROACHES TO THE DETERMINATION OF CHEMORESISTANCE OF HUMAN CANCER CELLS TO ANTI-CANCER DRUGS

par K. I. Kirsanov, K. A. Kuzin, T. I. Fetisov, E. A. Lesovaya, G. A. Belitskiy, M. G. Yakubovskaya
Publié 2020-07-01

INHIBITION OF REDD1 EXPRESSION FOR THE REDUCTION OF GLUCOCORTICOID-INDUCED SIDE EFFECTS

par E. S. Lylova, A. V. Savinkova, E. M. Zhidkova, K. I. Kirsanov, M. G. Yakubovskaya, I. V. Budunova, E. A. Lesovaya
Publié 2020-12-01

Anti-cancer activity of сuraxin CBL0137 on the models of acute leukemia in vitro

par T. I. Fetisov, K. I. Kirsanov, A. A. Borunova, M. N. Zatsepina, E. A. Lesovaya, T. N. Zabotina, G. A. Belitsky, M. G. Yakubovskaya
Publié 2019-12-01

Influence of DNA-binding compounds with cancer preventive activity on the mechanisms of gene expression regulation

par K. I. Kirsanov, O. A. Vlasova, T. I. Fetisov, R. G. Zenkov, E. A. Lesovaya, G. A. Belitsky, K. Gurova, M. G. Yakubovskaya
Publié 2019-01-01

Inhibition of glucocorticoid-induced REDD1 expression by rapamycin in breast cancer cells

par D. D. Grigorieva, E. M. Zhidkova, E. S. Lylova, D. V. Demina, K. I. Kirsanov, G. A. Belitsky, M. G. Yakubovskaya, E. A. Lesovaya
Publié 2022-03-01

Modern approaches for the screening of epigenetically active xenobiotics

par V. P. Maksimova, P. E. Bugaeva, E. M. Zhidkova, O. G. Usalka, E. A. Lesovaya, G. A. Belitsky, M. G. Yakubovskaya, K. I. Kirsanov
Publié 2019-11-01

Determination of chemoresistance of ovarian cancer cells in vitro

par K. A. Kuzin, T. I. Fetisov, R. I. Knyazev, L. Ya. Fomina, L. V. Meheda, E. A. Lesovaya, G. A. Belitsky, M. G. Yakubovskaya, K. I. Kirsanov
Publié 2019-12-01

Activation of interferon-α signaling by resveratrol, genistein and quercetin

par O. A. Vlasova, A. A. Borunova, A. Safina, I. V. Smetanina, E. A. Lesovaya, G. A. Belitsky, T. N. Zabotina, K. Gurova, K. I. Kirsanov, M. G. Yakubovskaya
Publié 2019-02-01

COMPARATIVE ANALYSIS OF BIOLOGICAL EFFECTS OF SELECTIVE ACTIVATOR OF THE GLUCOCORTICOID RECEPTOR CPDA ON DIFFERENT SUBTYPES OF BREAST CANCER CELL LINES

par E. M. Zhidkova, K. A. Kuzin, L. R. Tilova, A. V. Savinkova, O. I. Borisova, M. D. Lavrova, V. P. Maximova, K. I. Kirsanov, M. G. Yakubovskaya, E. A. Lesovaya
Publié 2017-12-01

EPIGENETIC EFFECTS OF ENZASTAURIN – A NEW ASPECT IN THE MECHANISM OF ACTION OF AN ANTICANCER DRUG FROM PROTEIN KINASE INHIBITORS

par V. P. Maksimova, J. V. Makus, O. G. Usalka, E. S. Lylova, P. E. Bugaeva, E. M. Zhidkova, D. A. Fedorov, O. P. Lizogub, E. A. Lesovaya, G. A. Belitsky, M. G. Yakubovskaya, K. I. Kirsanov
Publié 2020-09-01

Antitumor effect of the curaxin CBL0137 on the models of colon cancer

par T. I. Fetisov, L. R. Tilova, E. A. Lesovaya, E. E. Antoshina, T. G. Gor’kova, L. S. Trukhanova, O. V. Morozova, E. V. Shipaeva, R. V. Ivanov, A. A. Purmal, G. A. Belitskiy, M. G. Yakubovskaya, A. V. Gudkov, K. V. Gurova, K. I. Kirsanov
Publié 2016-09-01

VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT

par A. V. Savinkova, E. M. Zhidkova, L. R. Tilova, M. D. Lavrova, E. S. Lylova, K. A. Kuzin, A. Yu. Portyannikova, V. P. Maximova, A. V. Kholodova, O. A. Vlasova, T. I. Fetisov, K. I. Kirsanov, G. A. Belitskiy, M. G. Yakubovskaya, E. A. Lesovaya
Publié 2018-07-01